Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose bisoprolol in maintenance hemodialysis patients with asymptomatic left ventricular remodeling and diastolic dysfunction
ChiCTR-TNC-11001437Phase 4Completed
- Sponsor
- Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bisoprolol in left ventricular diastolic dysfunction (LVDD), Left ventricular remodeling (LVR) and end-stage kidney disease (ESKD), sponsored by Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: blood pressure, posterior wall thickness and 3 more. Started May 2009; status: completed.
02
Drugs
bisoprolol
03
Conditions
left ventricular diastolic dysfunction (LVDD)Left ventricular remodeling (LVR)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR-TNC-11001437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-11001437.